
EU regulator backs Pfizer/BioNTech BA.4/5-adapted COVID booster
By Natalie Grover (Reuters) -The European Medicines Agency (EMA) on Monday recommended a COVID-19 bo...
12th September, 2022

By Natalie Grover (Reuters) -The European Medicines Agency (EMA) on Monday recommended a COVID-19 bo...
12th September, 2022

By Natalie Grover and Ludwig Burger (Reuters) -The European Union’s drug regulator on Thursday backe...
2nd September, 2022

MADRID (Reuters) – A 20-month-old girl died after being struck on the head during a violent hailstor...
31st August, 2022

BEIJING/SHENZHEN, China (Reuters) -Several of China’s biggest cities imposed tougher COVID-19 curbs...
30th August, 2022

By Natalie Grover LONDON (Reuters) – The British scientists behind one of the major therapeutic COVI...
24th August, 2022

(Reuters) – Danish biotech firm Bavarian Nordic said on Thursday it has signed up a U.S.-based manuf...
19th August, 2022

By Emma Farge and Jennifer Rigby GENEVA/LONDON (Reuters) – Poxy McPoxface, TRUMP-22 or Mpox: these s...
16th August, 2022

By Natalie Grover LONDON (Reuters) -All adults in the United Kingdom will be offered a COVID-19 boos...
15th August, 2022

By Natalie Grover LONDON (Reuters) -Britain, the first country to approve a coronavirus vaccine in l...
15th August, 2022

By Marek Strzelecki WARSAW (Reuters) – Tonnes of dead fish have been hauled out of the River Oder, w...
12th August, 2022

By Sachin Ravikumar LONDON (Reuters) -A four-day “extreme heat” warning came into force in parts of...
11th August, 2022

By Jennifer Rigby LONDON (Reuters) – Supplies of a vaccine to prevent the deadly rotavirus infection...
10th August, 2022